User profiles for MATTHEW S. BLOCK
Matthew BlockAssociate Professor of Oncology, Mayo Clinic Verified email at mayo.edu Cited by 3704 |
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Advances in the treatment of metastatic melanoma have improved responses and survival.
However, many patients continue to experience resistance or toxicity to treatment, …
However, many patients continue to experience resistance or toxicity to treatment, …
Dose-response association of CD8+ tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer
EL Goode, MS Block, KR Kalli, RA Vierkant… - JAMA …, 2017 - jamanetwork.com
Importance Cytotoxic CD8 + tumor-infiltrating lymphocytes (TILs) participate in immune control
of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8 + …
of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8 + …
[HTML][HTML] Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
HNF1B is overexpressed in clear cell epithelial ovarian cancer, and we observed epigenetic
silencing in serous epithelial ovarian cancer, leading us to hypothesize that variation in this …
silencing in serous epithelial ovarian cancer, leading us to hypothesize that variation in this …
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer
…, P Haluska Jr, HJ Long, A Oberg, I Aderca, MS Block… - Cancer research, 2015 - AACR
Edmonston vaccine strains of measles virus (MV) have significant antitumor activity in
mouse xenograft models of ovarian cancer. MV engineered to express the sodium iodide …
mouse xenograft models of ovarian cancer. MV engineered to express the sodium iodide …
IL10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer
Ligation of programmed cell death-1 (PD-1) in the tumor microenvironment is known to
inhibit effective adaptive antitumor immunity. Blockade of PD-1 in humans has resulted in …
inhibit effective adaptive antitumor immunity. Blockade of PD-1 in humans has resulted in …
Fate of Fixed Points with Monopoles
We present an extensive quantum Monte Carlo study of the Néel to valence-bond solid (VBS)
phase transition on rectangular-and honeycomb-lattice SU (N) antiferromagnets in sign-…
phase transition on rectangular-and honeycomb-lattice SU (N) antiferromagnets in sign-…
The use of pembrolizumab for the treatment of metastatic uveal melanoma
…, RR McWilliams, SN Markovic, MS Block… - Melanoma …, 2016 - journals.lww.com
Uveal melanoma is a rare type of melanoma, with only five to seven cases per one million
persons diagnosed each year. Patients with metastatic melanoma of uveal origin tend to have …
persons diagnosed each year. Patients with metastatic melanoma of uveal origin tend to have …
[HTML][HTML] Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients
In ovarian cancer (OC), IL-17-producing T cells (Th17s) predict improved survival, whereas
regulatory T cells predict poorer survival. We previously developed a vaccine whereby patient…
regulatory T cells predict poorer survival. We previously developed a vaccine whereby patient…
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel
…, RA Vierkant, DN Rider, MS Block… - Human molecular …, 2013 - academic.oup.com
Ovarian cancer remains the leading cause of death in women with gynecologic malignancies,
despite surgical advances and the development of more effective chemotherapeutics. As …
despite surgical advances and the development of more effective chemotherapeutics. As …
First-in-class, first-in-human study evaluating LV305, a dendritic-cell tropic lentiviral vector, in sarcoma and other solid tumors expressing NY-ESO-1
N Somaiah, MS Block, JW Kim, GI Shapiro, KT Do… - Clinical Cancer …, 2019 - AACR
Purpose: LV305 is a modified, third-generation, nonreplicating, integration-deficient
lentivirus-based vector designed to selectively transduce dendritic cells in vivo. LV305 induces …
lentivirus-based vector designed to selectively transduce dendritic cells in vivo. LV305 induces …